Dilution Risk from Stock Option Exercise
First written in FY2023. 2 of 4 entries say "Mitigated", first in FY2024-Q1. Latest entry: FY2025.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2025MitigatedAnnual report
「As of the date of filing this document, stock acquisition rights issued as stock options represented 370,000 shares, equivalent to 11.8% of the company's 3,148,100 issued shares.」
Potential shares declined from 377,500, or 12.4%, to 370,000, or 11.8%, reducing the numerical dilution factor. The third and fourth series of rights remain outstanding. - FY2024RestatedAnnual report
「As of the date of filing this document, stock acquisition rights issued as stock options represented 377,500 shares, equivalent to 12.4% of the company's 3,048,100 issued shares.」
The disclosure continues to identify potential dilution of 377,500 shares, or 12.4% of issued shares. - FY2024-Q1MitigatedAnnual report
「The second series of stock acquisition rights expired because the rights became indeterminate. (Number of stock acquisition rights: 173; number of underlying shares: 17,300)」
The second series, representing 173 rights and 17,300 shares, expired and was one source of potential dilution. The total remaining stock options cannot be recalculated from this disclosure alone. - FY2023First statedAnnual report
「As of the date of filing this document, stock acquisition rights issued as stock options represented 377,500 shares, equivalent to 12.4% of the company's 3,048,100 issued shares.」
The company states that exercise over the next several years could affect per-share value and share-price formation.